Nejm, un anno di articoli sull'epidemia di Covid-19
Per fornire i dati necessari per generalizzare l'efficacia e la sicurezza degli esiti tra i gruppi razziali, gli studi clinici su Covid-19 ...
sezione
Nella <anchor>sezione</anchor> dedicata all'epidemia di Covid-19 il NEJM offre una "collection" di articoli e altre risorse, tra cui rapporti clinici, linee guida di gestione e commenti. Sono molti gli articoli che escono quotidianamente e aggiornano le conoscenze sulla malattia.
Coronavirus (Covid-19) | NEJM
Coronavirus (Covid-19) \| NEJM

[Skip to main content](#mainContent)

[![The New England Journal of Medicine homepage](/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-logo-166667e91992a5212bc723b03e45d39f.svg)](/ "The New England Journal of Medicine homepage")

[![Device Global Header](/pb-assets/contextual_messaging/device-glbal-header-2x-1515103614157.png)](/action/clickThrough?id=125703&url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fcoronavirus%26promo%3DONFQNRH5&loc=%2Fcoronavirus&placeholderId=101351&productId=1058)

[Subscribe\
\
or Renew](/action/clickThrough?id=125703&url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26promo%3DONFQNRH5&loc=%2Fcoronavirus&placeholderId=101351&productId=1058)

[Advanced Search](/search/advanced) SEARCH

[![The New England Journal of Medicine homepage](/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/nejm-small-logo-070df7a3f4d8cfa2e71c3c45bb4b172f.svg)](/ "The New England Journal of Medicine homepage")

- [SPECIALTIES](/medical-specialties)






- [Cardiology](/browse/specialty/cardiology)
- [Clinical Medicine](/browse/specialty/clinical-medicine)
- [Emergency Medicine](/browse/specialty/emergency-medicine)
- [Endocrinology](/browse/specialty/endocrinology)
- [Gastroenterology](/browse/specialty/gastroenterology)
- [Hematology/Oncology](/browse/specialty/hematology-oncology)
- [Infectious Disease](/browse/specialty/infectious-disease)
- [Nephrology](/browse/specialty/nephrology)
- [Neurology/Neurosurgery](/browse/specialty/neurology-neurosurgery)
- [Obstetrics/Gynecology](/browse/specialty/obstetrics-gynecology)
- [Pediatrics](/browse/specialty/pediatrics)
- [Pulmonary/Critical Care](/browse/specialty/pulmonary-critical-care)
- [View All Specialties](/medical-specialties)

- [TOPICS](/topics)






- [AI in Medicine](/ai-in-medicine)
- [Climate Crisis and Health](/browse/specialty/climate-change)
- [Coronavirus](/coronavirus)
- [Fundamentals of Health Law](/fundamentals-of-health-law)
- [Fundamentals of Medical Ethics](/fundamentals-of-medical-ethics)
- [Gray Matters](/gray-matters)
- [Health Policy](/browse/specialty/health-policy)
- [Medicine and Society](/medicine-and-society)
- [Nutrition in Medicine](/nutrition-in-medicine)
- [Race and Medicine](/race-and-medicine)
- [Recognizing Historical Injustices and the Journal](/recognizing-historical-injustices)
- [View All Topics](/topics)

- [MULTIMEDIA](/multimedia)






- [Podcasts](/rss-feed)
- [Double Takes](/double-take)
- [Illustrated Glossary](https://illustrated-glossary.nejm.org/)
- [Image Challenge](/image-challenge)
- [Images in Clinical Medicine](/browse/nejm-media-type/images-in-clinical-medicine)
- [Interactive Medical Cases](/browse/nejm-media-type/interactive-medical-case)
- [Plain Language/Research Summaries](/plain-language-research-summaries)
- [Quick Takes](/multimedia/quick-take-video)
- [Videos in Clinical Medicine](/browse/nejm-media-type/videos-in-clinical-medicine)
- [View All Multimedia](/multimedia)

- [current issue](/toc/nejm/current)






- [CURRENT ISSUE](/toc/nejm/current)
- [BROWSE RECENTLY PUBLISHED](/toc/nejm/recently-published)
- [BROWSE FULL ISSUE INDEX](/loi/nejm)

- [LEARNING/CME](/learning)






- [Weekly CME](/continuing-medical-education)
- [Obesity CME/CE](https://www.nejm.org/cme-ce/obesity)
- [VIEW ALL LEARNING/CME](/learning)

- [AUTHOR CENTER](/author-center/home)
- Publications






- [NEJM Catalyst](https://catalyst.nejm.org/)
- [NEJM Evidence](https://evidence.nejm.org/)
- [NEJM AI](https://ai.nejm.org/)
- [NEJM Journal Watch](https://www.jwatch.org/)

[Sign In](/sign-in?uri=/coronavirus)\|[Create Account](/action/storeProxy?action=register&promo=ONFLNRC1)

[Subscribe](/action/storeProxy?action=subscribe&promo=ONF4NRS1)

[![Device Global Header](/pb-assets/contextual_messaging/device-glbal-header-2x-1515103614157.png)](/action/clickThrough?id=125703&url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fcoronavirus%26promo%3DONFQNRH5&loc=%2Fcoronavirus&placeholderId=101351&productId=1058)

[Subscribe\
\
or Renew](/action/clickThrough?id=125703&url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26promo%3DONFQNRH5&loc=%2Fcoronavirus&placeholderId=101351&productId=1058)

# Coronavirus (Covid-19)

![](/pb-assets/images/editorial/banners/coronavirus_420x280-1581004685367.jpg)

A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.

Save

- [![Postacute Sequelae of SARS-CoV-2 Infection](/pb-assets/images/editorial/large/NEJMoa2403211_600x400-1722883229373.jpg)](/doi/full/10.1056/NEJMoa2403211)







- [Original Article](/browse/nejm-article-type/original-article)
- Jul 17, 2024
- FREE

#### [Postacute Sequelae of SARS-CoV-2 Infection](/doi/full/10.1056/NEJMoa2403211)

Y. Xie, T. Choi, and Z. Al-Aly

SARS-CoV-2 infection leads to postacute sequelae in many organ systems. In this study, the risk of postacute sequelae decreased over time but remained substantial even among vaccinated persons infected in the omicron era.

[Editorial Viral Variants, Vaccinations, and Long Covid — New Insights](doi/full/10.1056/NEJMe2407575)

- - [Sounding Board](/browse/nejm-article-type/sounding-board)
- Jul 31, 2024
- FREE

##### From the National Academy of Medicine

[![Long Covid Defined](/pb-assets/images/editorial/small/NEJMsb2408466_300x200-1722536039597.jpg)](/doi/full/10.1056/NEJMsb2408466)

#### [Long Covid Defined](/doi/full/10.1056/NEJMsb2408466)

E.W. Ely, L.M. Brown, and H.V. Fineberg

Members of the National Academies of Sciences, Engineering, and Medicine describe the process and rationale for the development of the 2024 definition of persistent Covid-19 symptoms (long Covid).

[Editorial From Evidence to Policy — Finding Authoritative Sources of Information on Health](doi/full/10.1056/NEJMe2409293)

- - [Perspective](/browse/nejm-article-type/perspective)
- Sep 11, 2024
- FREE

##### [Podcast: Intention to Treat](https://www.nejm.org/intention-to-treat)

[![What Exactly Is Long Covid? ](/pb-assets/images/editorial/small/ITT_podcast_300x200-1710869020613.jpg)](/doi/full/10.1056/NEJMp2407614)

#### [What Exactly Is Long Covid?](/doi/full/10.1056/NEJMp2407614)

The millions of people worldwide who are suffering from a vast array of disabling symptoms long after being infected with SARS-CoV-2 may eventually benefit from a new consensus definition of long Covid.

- - [Perspective](/browse/nejm-article-type/perspective)
- Aug 17, 2024

##### Efforts toward Equity

#### [Partnerships for Outbreak Response](/doi/full/10.1056/NEJMp2407283)

E. Davis, S. Mayer, and M. Pacilli

Recognizing that public health crises often hit hardest in underresourced communities, two academic medical centers have partnered with the Chicago Department of Public Health to provide rapid responses to outbreaks.

- [Perspective Transforming Narratives of Gun Violence](doi/full/10.1056/NEJMp2408294)
- [Perspective A Multitiered Mentorship Model — Fostering Inclusive Pathways to Health Careers](doi/full/10.1056/NEJMp2405205)
- [Perspective An Urban Farm–Anchored Produce Prescription Program — Food as Medicine and Economic Justice](doi/full/10.1056/NEJMp2407166)
- [Perspective Table Stakes for Equity — Consumer Demographic Data at a State-Based Marketplace](doi/full/10.1056/NEJMp2405798)

Save

- - [Original Article](/browse/nejm-article-type/original-article)
- Jul 17, 2024
- FREE

[![Nirmatrelvir–Ritonavir as Covid-19 Postexposure Prophylaxis](/pb-assets/images/editorial/small/NEJMdo007570_300x200-1721241351027.jpg)](/doi/full/10.1056/NEJMoa2309002)

#### [Nirmatrelvir–Ritonavir as Covid-19 Postexposure Prophylaxis](/doi/full/10.1056/NEJMoa2309002)

J. Hammond and Others

In this randomized trial, adults who had been exposed to a household contact with Covid-19 were given nirmatrelvir–ritonavir or placebo. Prophylaxis with nirmatrelvir–ritonavir did not prevent symptomatic Covid-19.

[Original Article Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19](doi/full/10.1056/NEJMoa2309003)

- - [Perspective](/browse/nejm-article-type/perspective)
- Jul 24, 2024
- FREE

#### [Déjà Vu All Over Again](/doi/full/10.1056/NEJMp2406427)

M.S. Sinha, W.E. Parmet, and G.S. Gonsalves

The federal government’s initial response to H5N1 avian influenza suggests that elected officials and other key decision makers may not be heeding the lessons from Covid-19.

- - [Perspective](/browse/nejm-article-type/perspective)
- Jun 29, 2024

#### [Academic Freedom in America](/doi/full/10.1056/NEJMp2314430)

E. Mullen, E.J. Topol, and A. Verghese

Public statements about Covid that a Stanford faculty member made in 2020 reinvigorated debate over academic freedom and institutional obligations, particularly in cases where public health is at stake.

- - [Correspondence](/browse/nejm-article-type/correspondence)
- May 29, 2024
- FREE

[![Vaccine Effectiveness against Omicron XBB.1.5 Subvariant](/pb-assets/images/editorial/small/NEJMc2402779_300x200-1718909421347.jpg)](/doi/full/10.1056/NEJMc2402779)

#### [Vaccine Effectiveness against Omicron XBB.1.5 Subvariant](/doi/full/10.1056/NEJMc2402779)

D.-Y. Lin and Others

A data survey of 1.8 million people in Nebraska showed that XBB.1.5 vaccine effectiveness was 52% against infection and 67% against hospitalization, despite a decline in circulating XBB.1.5 during data collection.

- - [Correspondence](/browse/nejm-article-type/correspondence)
- May 15, 2024
- FREE

[![Antibody Link for VITT and VITT-like Disorders](/pb-assets/images/editorial/small/NEJMc2402592_300x200-1715959707190.jpg)](/doi/full/10.1056/NEJMc2402592)

#### [Antibody Link for VITT and VITT-like Disorders](/doi/full/10.1056/NEJMc2402592)

J.J. Wang and Others

The antibody that mediates the occurrence of VITT associated with adenoviral-based Covid-19 vaccines is nearly identical to the antibodies produced in response to natural adenoviral infection.

- - [Original Article](/browse/nejm-article-type/original-article)
- Apr 03, 2024
- FREE

[![Nirmatrelvir–Ritonavir in Outpatients with Covid-19](/pb-assets/images/editorial/small/NEJMdo007471_300x200-1712173978763.jpg)](/doi/full/10.1056/NEJMoa2309003)

#### [Nirmatrelvir–Ritonavir in Outpatients with Covid-19](/doi/full/10.1056/NEJMoa2309003)

J. Hammond and Others

In fully vaccinated patients with risk factors for severe disease and patients (vaccinated or unvaccinated) without such risk factors, nirmatrelvir–ritonavir did not significantly shorten the time to alleviation of Covid-19 symptoms.

- [Editorial Treating Acute Covid-19 — Final Chapters Still Unwritten](doi/full/10.1056/NEJMe2402224)
- [Original Article Oral Nirmatrelvir–Ritonavir as Postexposure Prophylaxis for Covid-19](doi/full/10.1056/NEJMoa2309002)

[View more on Covid-19](/medical-research/coronavirus)

### [NEJM Covid-19 Update](https://interactives.nejm.org/iv/playlist_branded/index.html?media_id=chsWAwUH)

Listen to conversations with editors Eric Rubin and Lindsey Baden on the current coronavirus outbreak.

[![NEJM Covid-19 Update](/pb-assets/images/editorial/featuredTopics/coronavirus/coronavirus_podcast_300x200-1613748974693.jpg)](https://interactives.nejm.org/iv/playlist_branded/index.html?media_id=chsWAwUH)

### [HealthMap of the Coronavirus Outbreak](http://www.healthmap.org/ncov2019/)

[![publication image](/pb-assets/images/editorial/featuredTopics/coronavirus/coronavirushealthmap_300x200-1613748078617.jpg)](http://www.healthmap.org/ncov2019/)

The HealthMap team from Boston Children’s Hospital tracked publicly reported confirmed and suspected cases of Covid-19 throughout the world (last updated in August 2022).


### NEJM Journal Watch Summaries

- - September 10, 2024












[Atypical Immune Response to SARS-CoV-2 May Induce MIS-C](/action/clickThrough?id=127565&url=https%3A%2F%2Fwww.jwatch.org%2Fna57791%2F2024%2F09%2F10%2Fatypical-immune-response-sars-cov-2-may-induce-mis-c&loc=%2Fcoronavirus&placeholderId=101375&productId=1007)


[View more NEJM Journal Watch content](/action/clickThrough?id=127565&url=https%3A%2F%2Fwww.jwatch.org%2Fcovid-19&loc=%2Fcoronavirus&placeholderId=101375&productId=1007)

### NEJM Catalyst

- - January 17, 2024












[Boston Medical Center’s Communications Campaign to Build Confidence in Covid-19 Vaccines](/action/clickThrough?id=127679&url=https%3A%2F%2Fcatalyst.nejm.org%2Fdoi%2Ffull%2F10.1056%2FCAT.23.0322&loc=%2Fcoronavirus&placeholderId=101376&productId=1007)

- - December 20, 2023












[State Capacity Coordination Centers to Facilitate Access to Acute Care: A National Survey and Analysis](/action/clickThrough?id=127679&url=https%3A%2F%2Fcatalyst.nejm.org%2Fdoi%2Ffull%2F10.1056%2FCAT.23.0205&loc=%2Fcoronavirus&placeholderId=101376&productId=1007)

- - December 22, 2023












[Best Practices for Performing Safety Hemodialysis During a Pandemic](/action/clickThrough?id=127679&url=https%3A%2F%2Fcatalyst.nejm.org%2Fdoi%2Ffull%2F10.1056%2FCAT.22.0239&loc=%2Fcoronavirus&placeholderId=101376&productId=1007)


[View more NEJM Catalyst content](/action/clickThrough?id=127679&url=https%3A%2F%2Fcatalyst.nejm.org%2Fcovid-19&loc=%2Fcoronavirus&placeholderId=101376&productId=1007)

[![](/sda/127074/obesitySeminar-300x250-nodate2X.jpg)](/action/clickThrough?id=127074&url=https%3A%2F%2Fwww.nejm.org%2Fcme-ce%2Fobesity%3Fpromo%3DONFQCEO2%26query%3Dcm_rr%26utm_source%3Dnejm%26utm_medium%3Dcm%26utm_campaign%3Dcme_ce_obesity&loc=%2Fcoronavirus&placeholderId=101374&productId=1007)

Tap into groundbreaking research and clinically relevant insights

- [Subscribe](/action/clickThrough?id=128331&url=%2Faction%2FstoreProxy%3Faction%3Dsubscribe%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fcoronavirus%26promo%3DONFQAFAZ&loc=%2Fcoronavirus&placeholderId=101338&productId=1035)

Already a subscriber? [Sign In](/action/clickThrough?id=128331&url=%2Fsign-in&loc=%2Fcoronavirus&placeholderId=101338&productId=1035) or [Renew](/action/clickThrough?id=128331&url=%2Faction%2FstoreProxy%3Faction%3Drenew%26url%3Dhttps%253A%252F%252Fwww.nejm.org%252Fcoronavirus%26promo%3DONFQJRAN%26product%3Dnejm&loc=%2Fcoronavirus&placeholderId=101338&productId=1035)

![Devices](/sda/128331/footer-devices-2x.png)

#### ARTICLE CATEGORIES

- [Research](/browse/nejm-article-category/research)
- [Reviews](/browse/nejm-article-category/review)
- [Clinical Cases](/browse/nejm-article-category/clinical-cases)
- [Perspective](/browse/nejm-article-category/perspective)
- [Commentary](/browse/nejm-article-category/commentary)
- [Other](/browse/nejm-article-category/other)
- [Browse all Articles](/medical-article-index)
- [Current Issue](/toc/nejm/current)
- [Issue Index](/loi/nejm)

#### RESOURCES

- [Authors & Reviewers](/author-center/home)
- [Submit a Manuscript](/author-center/home)
- [Subscribers](/about-nejm/products-and-services)
- [Institutional Administrators](https://tools.ovid.com/ovidtools/nejm.html)
- [Media](/media)
- [Advertisers](/about-nejm/how-to-advertise)
- [Agents](/information-for-subscription-agents)
- [Permissions & Licensing](/about-nejm/permissions)
- [Reprints](/about-nejm/reprints)
- [NEJM CareerCenter](https://www.nejmcareercenter.org)

#### ABOUT US

- [About NEJM](/about-nejm/about-nejm)
- [NEJM Group](https://www.nejmgroup.org/)
- [Products & Services](/about-nejm/products-and-services)
- [Editors & Publishers](/about-nejm/editors-and-publishers)
- [Advertising Policies](/about-nejm/advertising-policies)
- [Contact Us](/contact-nejm)
- [Accessibility](/about-nejm/frequently-asked-questions?#Accessibility)
- [FAQs](/about-nejm/frequently-asked-questions)
- [Help](/about-nejm/help)
- [Site Feedback](/cdn-cgi/l/email-protection#9fecf6ebfaf9fafafbfdfefcf4dff1faf5f2b1f0edf8)

#### SUBSCRIPTIONS

- [Subscribe](/action/storeProxy?action=subscribe&promo=ONF4NRS3)
- [Renew](/action/storeProxy?action=renew&product=nejm&promo=ONFLNRR3&prc=ONFARN52)
- [Activate Subscription](/action/storeProxy?action=activate&promo=ONFLNAA1)
- [Create Account](/action/storeProxy?action=register&promo=ONFLNRC4)
- [Manage Account](https://myaccount.nejm.org)
- [Pay Bill](/action/storeProxy?action=paybill&product=nejm&promo=BNFLPBA1)
- [Institution Subscriptions](https://info.lww.com/Request-NEJM-for-your-institution.html)
- [Special Content](https://myaccount.nejm.org/special-content)

#### STAY CONNECTED

- [Email Alerts](https://myaccount.nejm.org/emails?section=NEJM)
- [Create Account](/action/storeProxy?action=register&promo=ONFLNRC3)
- [Apps](/about-nejm/products-and-services)
- [NEJM CareerCenter](https://www.nejmcareercenter.org)
- [Podcasts](/rss-feed/)
- [RSS Feed](/rss-feed/)
- [Remote Access](/about-nejm/institutional-access)

#### FOLLOW US

- [Facebook](https://www.facebook.com/TheNewEnglandJournalofMedicine)
- [X (formerly Twitter)](https://twitter.com/nejm)
- [Instagram](https://www.instagram.com/nejm/)
- [Youtube](https://www.youtube.com/user/NEJMvideo)
- [LinkedIn](https://www.linkedin.com/company/nejm-group)

#### JOURNALS

- [The New England Journal of Medicine](https://www.nejm.org/)
- [NEJM Catalyst Innovations in Care Delivery](https://catalyst.nejm.org/)
- [NEJM Evidence](https://evidence.nejm.org/)
- [NEJM AI](https://ai.nejm.org/)

Copyright © 2024 [Massachusetts Medical Society](https://www.massmed.org/). All rights reserved. Electronic ISSN 1533-4406. Print ISSN 0028-4793.

The content of this site is intended for health care professionals.

- [Copyright](https://www.nejmgroup.org/legal/copyright-information.htm)
- [Terms](https://www.nejmgroup.org/legal/terms-of-use.htm)
- [Privacy Policy](https://www.nejmgroup.org/legal/privacy-policy.htm)

[![NEJM Group logo](/specs/products/mms-nextgen/mms/releasedAssets/images/other-images/logo_group.svg)](https://www.nejmgroup.org/ "NEJM Group")

Back to top